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Demystifying Imaging Laboratory Accreditation
Geoffrey A. Rose, MD,* Neil J. Weissman, MDyt is self-evident that patients expect high quality
of the services they receive. For this reason,
procedural-based medical (therapeutic) services
have long been subject to some form of quality
assessment. In the same vein, it is also appropriate
that similar expectations have recently come about
for cardiovascular (CV) imaging (diagnostic) ser-
vices. In this report, we provide the background of
CV laboratory accreditation and explore what the
future holds in assessing quality in CV imaging.
BACKGROUND AND THE
FORMATION OF THE INTERSOCIETAL
ACCREDITATION COMMISSION
The performance of high-quality CV imaging, like
procedural-based work, requires professionals who:
1) are well trained; 2) have access to the right
technologies; 3) use protocols that ensure the thor-
oughness of image data gathering; and 4) then
synthesize and transform those data into clinically
meaningful information that advances care. This is
the so-called imaging chain. Unlike procedural-
based work, however, clinical beneﬁt or harm is
less discernible with CV imaging. Precisely how do
we measure the impact of false-positive stress test
results? Or account for the cascade of events that
arise from overestimating the degree of valvular
regurgitation or carotid stenosis? In contrast to
deploying a stent or implanting a pacemaker, how to
analyze the direct clinical impact of CV imagingdits
qualitydhas remained elusive.
This difﬁculty has long been recognized within the
imaging community. Because determining clinical
effectiveness has been problematic, attention instead
has focused on evaluating the discrete individual el-
ements of the CV imaging chain. Performance*Carolinas HealthCare System, Charlotte, North Carolina; and yMedStar
Health Research Institute, Washington, DC. Dr. Rose is Chair of the
Intersocietal Accreditation Commission and Dr. Weissman is Chair of the
Cardiovascular Imaging Section and Leadership Council.measures for each step are aggregated to serve as a
proxy for overall quality. On the basis of the classic
Donabedian model for quality assessment, 3 distinct
domains within CV imaging lend themselves to such
analysis: structure, process, and outcome. The prin-
ciples of this approach are straightforward. To
perform well in a reliable manner, a laboratory must
have a basic underlying structure, in terms of its
equipment, facility, and personnel resources. Next,
there needs to be some common processes for
applying the technical resources and reporting the
clinical information. Last, results need to be moni-
tored and compared with an external reference source
to inform and improve the laboratory’s performance.
In 1990, leaders in the ﬁeld of vascular imaging
formed an organization to develop standards for
vascular imaging along these lines. This organiza-
tion became known as the Intersocietal Commission
for the Accreditation of Vascular Laboratories
(ICAVL). The group determined speciﬁc elements
of laboratory structure, outlining expectations for
the education and certiﬁcation of medical and
technical staff members. Essential equipment was
deﬁned. The group drafted imaging protocols
encompassing necessary views and report elements.
They required efforts to correlate a laboratory’s re-
sults with clinical information derived from other
modalities. Sponsoring societies embraced this
approach and encouraged vascular laboratories to
submit applications for evaluation by ICAVL.
Receipt of accreditation from ICAVL conferred
upon a laboratory an acknowledgement of its quality
by an external referee.
What was different about ICAVL, compared
with licensing or certiﬁcation agencies, was that the
standards were developed and updated by imaging
peers within the practicing community. Moreover,
the process of submitting an accreditation applica-
tion in and of itself was designed to be a quality
improvement initiative for a laboratory. A structured
approach to self-examination coupled with external
validation and feedback provided a clear path toward
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Figure 1. Intersocietal Accreditation Commission Application Receipt by
Year and the Inﬂuence of Payment Policies
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213a laboratory’s improvement. Rather than receiving a
pass/fail outcome, as one might expect when taking
a board examination, laboratories that initially did
not meet the bar were given very speciﬁc direction as
to how they could improve. Laboratories that per-
formed at an overall level that merited accreditation
also received feedback as to how they could perform
even better in the future.
This idea of accreditation as a peer-driven
pathway to quality improvement began to take
hold within other imaging disciplines. Echocardi-
ography followed in 1996, and nuclear cardiology in
1997. Magnetic resonance and computed tomo-
graphic imaging followed after 2000 and 2007,
respectively. Although each entity functioned as an
independent business unit, all were based on the
same principles: peers authoring standards, and
peers evaluating a laboratory’s conformance with
those standards. In 2008, to achieve economies of
scale and streamline operations, these individual
accrediting entities merged into 1 organization, the
Intersocietal Accreditation Commission (IAC).
CURRENT STATE OF
LABORATORY ACCREDITATION
As more practitioners seek accreditation for their
CV imaging laboratories, payers have taken notice.
In some areas of the United States, accreditation
is no longer a badge of distinction marking a
laboratory’s quality but instead a prerequisite for
payment. The adoption of accreditation re-
quirements by some local Medicare carriers and
private payers has driven application volumes
(Fig. 1) and sparked dialogue as to how stringent
accreditation requirements should be. Congress
ofﬁcially weighed in on this issue by passing the
Medicare Improvements for Patients and Providers
Act of 2008. With this law, the Centers for
Medicare and Medicaid Services were mandated to
link reimbursement with accreditation for advanced
imaging services offered outside of the hospital
setting. Three accrediting organizations were
recognized: the American College of Radiology,
The Joint Commission, and IAC. With the passage
of this legislation, accreditation morphed from an
accolade that signiﬁed quality work to a necessary
hurdle to overcome in order to practice.
So where does IAC stand today, and where is it
headed? At present, across 5 imaging modalities
and 2 therapeutic divisions, IAC has accredited
8,372 laboratories, conducting operations at a total
of 13,239 sites. There are some 35 professional
societies that serve as sponsoring organizations forthe various accreditation divisions. IAC is itself
accredited, having achieved certiﬁcation by the
International Organization for Standardization
for quality management and information security
management systems. Thus, as an organization
that renders judgments on quality within imaging,
IAC has practiced what it preaches by going
through the rigorous process of internal analysis
and external review.
Divisional boards of IAC meet at least twice
annually, and the parent IAC board meets quarterly
to develop and enact initiatives aimed not only to
improve operations but also reduce the work of
those who submit applications. Some examples are
as follows: To simplify the accreditation process,
IAC has adopted a common online application, so
that data submitted for accreditation in one mo-
dality can be easily transferred to applications in
other modalities. Further efforts to simplify an in-
stitution’s multimodality application are being
developed. The ability to submit images online in a
secure manner compliant with the Health Insur-
ance Portability and Accountability Act is also be-
ing developed. Common quality improvement
guidelines are being authored, so that improvement
can be gauged in standard fashion within each
modality. The incorporation of appropriate use
criteria in laboratories’ operations has now become
part of each modality’s standards. But perhaps
the broadest effort of IAC over the past 2 years has
been the creation of an internally funded research
program, the mission of which is to demonstrate
the value of accreditation on improving the quality
of CV imaging. It is through a program of research
that we hope to get beyond today’s baseline of
expert consensus to a more informed and validated
approach that links laboratory performance and
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214clinical quality. The results of these research efforts
are beginning to appear in published, peer-reviewed
research.
THE FUTURE
The practice of medicine in the United States is
undergoing dramatic change, from a system whose
economic underpinning has been based on the
volume of services to one instead based on the value
of those services rendered. Ongoing research will
help us better understand the speciﬁc relationship of
laboratory accreditation to the provision of quality
and value of CV imaging. In the meantime, payers
have not only begun to accept accreditation as a
surrogate for quality but also to expect it as a con-
dition for payment.
Recently, IAC held a forum in Washington,
DC, inviting various stakeholders from the payer
community, government, patient advocacy groups,
practicing physicians, technical staff, and spon-
soring societies to provide feedback as to how to
strengthen accreditation and how to make it more
meaningful. Before the open “listening” phase of
the meeting, IAC communicated the followingwithout equivocation: IAC is a certiﬁcation agency,
not a regulatory agency. IAC is not the imaging
police. The divisional board members of each IAC
modality are imaging experts tapped from the ac-
ademic and private practice communities. They
author standards that encompass their best efforts
in capturing elements deemed both essential yet
practical in providing high-quality CV imaging.
At the forum, stakeholders expressed that for
some, IAC standards are too lax. For others, they
are too rigid. For most, the accreditation process is
too time-consuming and expensive. The IAC
boards will process this feedback and work on action
plans in response and to further the IAC mission:
improving health care through accreditation.
In summary, laboratory accreditation in CV im-
aging is now well established for vascular, echo-
cardiographic, nuclear, computed tomographic,
and magnetic resonance imaging and is a recog-
nized endorsement of the quality of imaging pro-
vided by a laboratory. Further research linking
accreditation, outcomes, and value, along with
ongoing feedback from stakeholders, will help
continue to reﬁne the process and meet the medical
community’s needs.
